19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Alcohol consumption has been associated with poor antiretroviral therapy (ART) adherence but less is known about its relationship to HIV viral suppression, or whether certain drinking patterns have a stronger association than others. The objectives of this study were to determine the association of different patterns of alcohol consumption to HIV viral suppression and ART adherence, and to determine whether any associations of alcohol with HIV viral suppression were mediated by poor ART adherence.

          Methods

          This observational study used baseline data from 619 HIV+ participants, recruited across 8 clinical and community settings across Florida as part of the Florida Cohort from 2014 to 2016. Alcohol consumption was measured by self-report, and grouped into four categories: heavy drinking (>7/week for women or >14 drinks/week for men); binge, but not heavy drinking (≥4 or >5 drinks/occasion for women and men, respectively), low level drinking (neither heavy nor binge), and abstinence. Serum HIV RNA measurements were obtained from statewide HIV surveillance data, and durable viral suppression was defined as achieving HIV viral suppression (<200 copies/ml) at every assessment in the past 12 months.

          Results

          The majority of the 619 participants were male (63%) and aged 45 or greater (65%). The proportion of participants with heavy, binge, low-level drinking and abstinence was 9, 25, 37 and 30%, respectively. Optimal ART adherence (≥95%) was reported by 68%, and 60% achieved durable viral suppression. In multivariable analysis controlling for demographic factors, drug use, and homelessness, heavy drinking (compared to abstinence) was associated with increased odds of failing to achieve durable viral suppression (OR 2.16, 95% CI 1.08–4.32) whereas binge drinking alone was not significantly associated with this outcome (OR 1.04, 95% CI 0.64–1.70). Both heavy drinking and binge drinking were significantly associated with suboptimal ART adherence. Mediation analyses suggested that only a small proportion of the relationship between heavy drinking and suboptimal viral suppression was due to poor ART adherence.

          Conclusions

          Exceeding weekly recommended levels of alcohol consumption (heavy drinking) was significantly associated with poor HIV viral suppression and ART non-adherence, while binge drinking was associated with suboptimal ART adherence in this sample. Clinicians should attempt to address heavy drinking in their patients with HIV.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Alcohol use and antiretroviral adherence: review and meta-analysis.

          Alcohol use is frequently implicated as a factor in nonadherence to highly active antiretroviral therapy (HAART). There have not been efforts to systematically evaluate findings across studies. This meta-analysis provides a quantitative evaluation of the alcohol-adherence association by aggregating findings across studies and examining potential moderators. Literature searches identified 40 qualifying studies totaling over 25,000 participants. Studies were coded on several methodological variables. In the combined analysis, alcohol drinkers were approximately 50%-60% as likely to be classified as adherent [odds ratio (OR) = 0.548, 95% confidence interval (CI): 0.490 to 0.612] compared with abstainers (or those who drank relatively less). Effect sizes for problem drinking, defined as meeting the National Institute on Alcohol Abuse and Alcoholism criteria for at-risk drinking or criteria for an alcohol use disorder, were greater (OR = 0.474, 95% CI = 0.408 to 0.550) than those reflecting any or global drinking (OR = 0.604, 95% CI = 0.531 to 0.687). Several variables moderated the alcohol-adherence association. Results support a significant and reliable association of alcohol use and medication nonadherence. Methodological variables seem to moderate this association and could contribute to inconsistent findings across studies. Future research would benefit from efforts to characterize theoretical mechanisms and mediators and moderators of the alcohol-adherence association.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.

            Alcohol use disorders (AUDs) are highly prevalent and associated with non-adherence to antiretroviral therapy, decreased health care utilization and poor HIV treatment outcomes among HIV-infected individuals. To systematically review studies assessing the impact of AUDs on: (1) medication adherence, (2) health care utilization and (3) biological treatment outcomes among people living with HIV/AIDS (PLWHA). Six electronic databases and Google Scholar were queried for articles published in English, French and Spanish from 1988 to 2010. Selected references from primary articles were also examined. Selection criteria included: (1) AUD and adherence (N=20); (2) AUD and health services utilization (N=11); or (3) AUD with CD4 count or HIV-1 RNA treatment outcomes (N=10). Reviews, animal studies, non-peer reviewed documents and ongoing studies with unpublished data were excluded. Studies that did not differentiate HIV+ from HIV- status and those that did not distinguish between drug and alcohol use were also excluded. Data were extracted, appraised and summarized. Our findings consistently support an association between AUDs and decreased adherence to antiretroviral therapy and poor HIV treatment outcomes among HIV-infected individuals. Their effect on health care utilization, however, was variable. Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Predictors of disease progression in HIV infection: a review

              During the extended clinically latent period associated with Human Immunodeficiency Virus (HIV) infection the virus itself is far from latent. This phase of infection generally comes to an end with the development of symptomatic illness. Understanding the factors affecting disease progression can aid treatment commencement and therapeutic monitoring decisions. An example of this is the clear utility of CD4+ T-cell count and HIV-RNA for disease stage and progression assessment. Elements of the immune response such as the diversity of HIV-specific cytotoxic lymphocyte responses and cell-surface CD38 expression correlate significantly with the control of viral replication. However, the relationship between soluble markers of immune activation and disease progression remains inconclusive. In patients on treatment, sustained virological rebound to >10 000 copies/mL is associated with poor clinical outcome. However, the same is not true of transient elevations of HIV RNA (blips). Another virological factor, drug resistance, is becoming a growing problem around the globe and monitoring must play a part in the surveillance and control of the epidemic worldwide. The links between chemokine receptor tropism and rate of disease progression remain uncertain and the clinical utility of monitoring viral strain is yet to be determined. The large number of confounding factors has made investigation of the roles of race and viral subtype difficult, and further research is needed to elucidate their significance. Host factors such as age, HLA and CYP polymorphisms and psychosocial factors remain important, though often unalterable, predictors of disease progression. Although gender and mode of transmission have a lesser role in disease progression, they may impact other markers such as viral load. Finally, readily measurable markers of disease such as total lymphocyte count, haemoglobin, body mass index and delayed type hypersensitivity may come into favour as ART becomes increasingly available in resource-limited parts of the world. The influence of these, and other factors, on the clinical progression of HIV infection are reviewed in detail, both preceding and following treatment initiation.
                Bookmark

                Author and article information

                Contributors
                cookrl@ufl.edu
                zzhou0412@ufl.edu
                kelsona@ufl.edu
                jennifer.janelle@medicine.ufl.edu
                jmorano@health.usf.edu
                csomboon@health.usf.edu
                willie.carter@flhealth.gov
                gibanez@fiu.edu
                nwhitehead@phhp.ufl.edu
                christacook@ufl.edu
                roncohen@ufl.edu
                brumback@phhp.ufl.edu
                kbryant@willco.niaaa.nih.gov
                Journal
                Addict Sci Clin Pract
                Addict Sci Clin Pract
                Addiction Science & Clinical Practice
                BioMed Central (London )
                1940-0632
                1940-0640
                27 September 2017
                27 September 2017
                2017
                : 12
                : 22
                Affiliations
                [1 ]ISNI 0000 0004 1936 8091, GRID grid.15276.37, Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, , University of Florida, ; PO Box 100231, Gainesville, FL 32610 USA
                [2 ]ISNI 0000 0004 1936 8091, GRID grid.15276.37, Department of Medicine, , University of Florida, ; Gainesville, FL USA
                [3 ]ISNI 0000 0004 1936 8091, GRID grid.15276.37, Department of Clinical and Health Psychology, , University of Florida, ; Gainesville, FL USA
                [4 ]ISNI 0000 0004 1936 8091, GRID grid.15276.37, Department of Family, Community, and Health System Science, College of Nursing, , University of Florida, ; Gainesville, FL USA
                [5 ]ISNI 0000 0004 1936 8091, GRID grid.15276.37, Department of Biostatistics, , University of Florida, ; Gainesville, FL USA
                [6 ]ISNI 0000 0001 2353 285X, GRID grid.170693.a, Division of Infectious Diseases and International Medicine, , University of South Florida Morsani College of Medicine, ; Tampa, FL USA
                [7 ]ISNI 0000 0001 2353 285X, GRID grid.170693.a, Department of Internal Medicine, , University of South Florida Morsani College of Medicine, ; Tampa, FL USA
                [8 ]Florida Department of Health, Orange County Office of Clinical Services, Disease Investigation and Research, Orlando, FL USA
                [9 ]ISNI 0000 0001 2110 1845, GRID grid.65456.34, Department of Epidemiology, , Florida International University, ; Miami, FL USA
                [10 ]ISNI 0000 0004 0481 4802, GRID grid.420085.b, National Institute on Alcohol Abuse and Alcoholism, ; Bethesda, MD USA
                Author information
                http://orcid.org/0000-0002-7770-3754
                Article
                90
                10.1186/s13722-017-0090-0
                5615807
                28950912
                9f41fb2c-60b5-4a08-b756-47cc96cdc26e
                © The Author(s) 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 13 March 2017
                : 18 August 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000027, National Institute on Alcohol Abuse and Alcoholism;
                Award ID: U24 AA022002
                Award Recipient :
                Funded by: State of Florida via the University of Miami Miller School of Medicine Institute for AIDS and Emerging Infectious Diseases
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Health & Social care
                alcohol consumption,binge drinking,hiv,viral suppression,art adherence
                Health & Social care
                alcohol consumption, binge drinking, hiv, viral suppression, art adherence

                Comments

                Comment on this article